Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus

Accumulating evidence suggests that metformin reduces the incidence and mortality of colorectal cancer (CRC). However, underlying mechanisms have not been fully clarified. The aim of this study was to examine the pathological characteristics of resected CRC from patients treated with metformin for t...

Full description

Saved in:
Bibliographic Details
Published in:Cancer science Vol. 111; no. 11; pp. 4012 - 4020
Main Authors: Saito, Akira, Kitayama, Joji, Horie, Hisanaga, Koinuma, Koji, Ohzawa, Hideyuki, Yamaguchi, Hironori, Kawahira, Hiroshi, Mimura, Toshiki, Lefor, Alan Kawarai, Sata, Naohiro
Format: Journal Article
Language:English
Published: England John Wiley & Sons, Inc 01.11.2020
John Wiley and Sons Inc
Subjects:
ISSN:1347-9032, 1349-7006, 1349-7006
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first